More on EIKN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $9.95 |
|
|||
| Open | $9.63 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $9.94 | ||||
| Day Low | $9.56 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 181,174 | ||||
- Eikon Therapeutics to join Russell 3000 index on June 26
- Eikon Therapeutics to Join the Russell 3000® Index
- Eikon Therapeutics appoints Ma. Fatima Francisco to board of directors
- Eikon Therapeutics Announces the Appointment of Ma. Fatima D. Francisco to its Board of Directors
- Eikon Therapeutics (EIKN) Reiterated at Overweight by Cantor Fitzgerald
- Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
- Eikon Therapeutics to present six abstracts at 2026 ASCO meeting
- Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
- Eikon Therapeutics Reports First Quarter 2026 Financial Results and Provides Clinical Updates
- Mizuho stays Outperform rated on Eikon Therapeutics Inc. (EIKN) following FY25 earnings and pipeline update
Entities mentioned with EIKN
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Mizuho | View Related Stories »
- JPMorgan | View Related Stories »
- Morgan Stanley | View Related Stories »
- Earnings | View Related Stories »
- Show More...
